Antinociceptive Synergy between Δ9-Tetrahydrocannabinol and Opioids after Oral Administration
Abstract
The analgesic effects of opioids, such as morphine and codeine, in mice are enhanced by oral administration of the cannabinoid delta(9)-tetrahydrocannabinol (delta(9)-THC). However, isobolographic analysis has never been done to confirm a synergy between delta(9)-THC and morphine or codeine via oral routes of administration. To determine the nature of the interaction between these drugs for pain relief and extend previous experimental results, we performed an isobolographic analysis to evaluate for additivity or synergy in the tail-flick test. Fixed-ratio combinations of delta(9)-THC with either morphine or codeine were tested for antinociceptive effects. The experimentally derived ED(50) for each combination was compared with the theoretical additive ED(50), using an isobolographic analysis. All of the fixed-ratio combinations tested produced greater antinociception (synergy) than predicted from simple additivity. These findings suggest that the use of a low-dose combination of analgesics is a valid and effective approach for the treatment of pain and necessitates further study.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The combination of THC and morphine produces synergistic antinociception in the tail flick assay.
“Further studies indicate that the combination of THC and morphine produces synergistic antinociception in the tail flick assay (Cichewicz and McCarthy, 2003).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Cichewicz and McCarthy, 2003
The citation lists haven’t been fetched yet
References 41 · Cited by 154
- Authors
- Cichewicz, D. L., & McCarthy, E. A.
- Affiliations
- Virginia Commonwealth University (US)
- ORCID
- McCarthy, Erin A.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 304
- Issue
- 3
- Pages
- 1010-1015
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W1982331370
- Cited by
- 154
- References
- 41
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 7 · 2023: 6 · 2022: 2 · 2021: 8 · 2020: 10 · 2019: 8 · 2018: 7 · 2017: 11 · 2016: 6 · 2015: 4 · 2014: 8 · 2013: 5 · 2012: 9
- FWCI
- 5.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k02da000186-09)
- National Institute on Drug Abuse (DA 07027, DA 05274, K02 DA-00186, T32DA007027)
- Topics
- Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- delta-9-tetrahydrocannabinol, cannabinoids, opioids, morphine, codeine, antinociception, drug synergy, isobolographic analysis, fixed-ratio combination, oral administration, analgesic combination therapy, tail-flick test
- MeSH terms
- Administration, Oral, Analgesics, Animals, Codeine, Dose-Response Relationship, Drug, Drug Synergism, Drug Therapy, Combination, Male, Mice, Inbred ICR, Morphine, Narcotics, Pain, Dronabinol, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review